New directions in the neoadjuvant treatment of tumors of the upper GI tract;Neue Therapieansätze bei Tumoren des oberen Gastrointestinaltrakts (Oesophagus, Magen)

Chirurg

Volumn 71, Issue 12, 2000, Pages 1447-1457

  Sendler, A ^a   Stein, H J ^a   Fink, U ^a   Siewert, J R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Esophageal cancer; Gastric cancer; Neoadjuvant therapy

Indexed keywords

ADJUVANT THERAPY; ESOPHAGUS TUMOR; HUMAN; MORTALITY; MULTIMODALITY CANCER THERAPY; REVIEW; STOMACH TUMOR; SURVIVAL RATE;

COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0034572614     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040051243     Document Type: Article

References (74)

1. Adelstein DJ, Rice TW, Becker M, Larto MA, et al (1997) Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 80: 1011
2. Adelstein DJ, Rice TW, Rybicki LA, Becker M, et al (1998) Concurent chemoradiotherapy and surgery for esophageal cancer: Updated results. Can J Gastroenterol 12 [Suppl B]: 26
3. Adelstein DJ, Rice TW, Rybicki LA, Larto MA, et al (2000) Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy. J Clin Oncol 18: 2032
4. Ajani JA, Mansfield PF, Lynch PM, Pisters PW, et al (1999) Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. J Clin Oncol 17: 2403
5. Al Sarraf M, Martz K, Herskovic A, Leichman L, et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15: 277
6. Alexander EP, Lipman T, Harmon J, Wadleigh R (2000) Aggressive multimodality therapy for stage III esophageal cancer: a phase I/II study. Ann Thorac Surg 69: 363
7. Ancona E, Ruol A, Santi S, Chiarion V, et al (1998) Prognostic role of downstaging after neoadjuvant chemotherapy in potentially resectable (T2-3 Nx M0) esophageal squamous cell carcinoma. Can J Gastroenterol 12 [Suppl B]: 243
8. Apinop C, Puttisak P, Preecha N (1994) A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41: 391
9. Araujo CM, Souhami L, Gil RA, Carvalho R, et al (1991) A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 67: 2258
10. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE (1996) Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 14: 156
11. Belani CP, Luketich JD, Landreaneau RJ, Kim R, -2261 (1997) Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus. Semin Oncol 24: 19
12. Bidoli P, Spinazze S, Valente M, Zucali R, et al (1990) Combined chemotherapy (CT)-radiotherapy (RT) +/-esophagectomy (E) in squamous cell cancer of the esophagus (SCCE). Proc Am Soc Clin Oncol 9: 424 (A)
13. Bosset JF, Gignoux M, Triboulet JP, Tiret E, et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337: 161
14. Brücher BL, Weber W, Fink U, Bauer M, et al (2000) Predictivity of PET in the response evaluation after neoadjuvant RTX/CTX esophageal cancer. J Cancer Res Clin Oncol 126: 33 (A)
15. Burke EC, Karpeh MS, Conlon KC, Brennan MF (1997) Laparoscopy in the management of gastric adenocarcinoma. Ann Surg 225: 262
16. Coia LR, Minsky BD, Berkey BA, John MJ, et al (2000) Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J Clin Oncol 18: 455
17. Coia LR, Minsky BD, John MJ, Haller DG, et al (1999) The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992-1994 Patterns of Care Study. Cancer 85: 2499
18. Couper GW, McAteer D, Wallis F, Norton M, et al (1998) Deection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric. Br J Surg 85: 1403
19. Earle CC, Maronn JA (1998) Adjuvant chemotherapy after curative resection for gastric cancer: revisiting a meta-analysis of randomized trials. Proc Am Soc Clin Oncol 17: 263 (A)
20. Faß I, Zengel K, Reinicke T, Jansen M, Schumpelick V (1998) Intraperitonela therapy with carbon-absorbed mitomycin C in gastric cancer with serosal invasion. J Cancer Res Clin Oncol 124: (A)
21. Fink U, Ott K, Dittler HJ, Helmberger H, et al (1999) Neoadjuvant cisplatinum, leucovorin and fluorouracil (PLF) in adequately staged patients with locally advanced gastric carcinoma. Proc Am Soc Clin Oncol 18: 1044 (A)
22. Fink U, Schuhmacher C, Stein HJ, Busch R, et al (1995) Preoperative chemotherapy for stage III-IV gastric carcinoma: feasibility, response and outcome after complete resection. Br J Surg 82: 1248
23. Fink U, Stein HJ, Schuhmacher C, Wilke HJ (1995) Neoadjuvant chemotherapy for gastric cancer: update. World J Surg 19: 509
24. Fink U, Stein HJ, Siewert JR (1998) Multimodale Therapie der Tumoren der oberen Gastrointestinaltrakts. Chirurg 69: 349
25. Fink U, Stein HJ, Wilke H, Roder JD, Siewert JR (1995) Multimodal treatment for squamous cell esophageal cancer. World J Surg 19: 198
26. Floriani I, Mar E, Cascinu S, Tinazzi A, et al (2000) Efficacy of adjuvant chemotherapy after durative resection for gastric cancer: a meta-analysis for published randomized trials. Proc Am Soc Clin Oncol 19: 1017 (A)
27. Gonzalez G, Crombet T, Catala M, Mirabal V, et al (1998) A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial. Ann Oncol 9: 431
28. Grundei T, Fink U, Matzen K, Sendler A, et al (1997) Neoadjuvant chemotherapy with cisplatin, leucovorin and 5-fluoouracil (PLF) for locally advanced gastric cancer. In: Siewert JR, Roder JD (eds) Progress in gastric cancer. Monduzzi Editore, Bologna, p 1323
29. Hagiwara A, TakahashiT, Kojima O, Sawai K, et al (1992) Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 339: 629
30. Hayashi K, Danenberg K, Metzger R, Solonga D, et al (1996) Differential thymidylate synthase (TS) gene expression in squamous cell carcinoma and adenocarcinoma of the esophagus. Proc Am Soc Clin Oncol 15: 499 (A)
31. Hermans J, Bonenkamp JJ (1994) Reply to a letter. J Clin Oncol 12: 879
32. Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, et al (1993) Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 11: 1441
33. Ilson D, Arquette M, Costa F, Bains M, et al (1997) Preoperative paclitaxel/cisplatin in esophageal carcinoma: a phase II multicenter trial. Proc Am Soc Clin Oncol 16: (A)
34. Ilson DH, Ajani J, Bhalla K, Forastiere A, et al (1998) Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 16: 1826
35. Kelsen D, Karpeh M, Schwartz G, Christman K (1994) Neoadjuvant and postoeprative chemotherapy ofr high risk patients with gastric cancer. Proc Am Soc Clin Oncol 13: 195 (A)
36. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, et al (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339: 1979
37. Kok TC, van Lanschot J, Siersema PD, Van Overhagen H, Tilanus HW (1997) Neoadjuvant chemotherapy in operable squamous cell cancer: final report of a phase III multicenter randomized trial. Proc Am Soc Clin Oncol 17: 984 (A)
38. Kok TC, van Lanschot JJB, Siesema PD, Klooswijk BIJ, et al (1998) Neo-adjuvant chemotherapy compared with surgery in esophageal squamous cell cancer. Can J Gastroenterol 12 [Suppl B]: 297
39. Krasna MJ, Mao YS, Sonett JR, Tamura G, et al (1999) p53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients. Ann Thorac Surg 68: 2021
40. Laterza E, deManzoni G, Tedesco P, Guglielmi A, (1999) Induction chemo-radiotherapy for squamous cell carcinoma of the thoracic esophagus: long-term results of a phase II study. Ann Surg Oncol 6: 777
41. Law S, Fok M, Chow S, Chu KM, Wong J (1997) Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114: 210
42. Law S, Kwong DLW, Tung HM, Chu KM, et al (1998) Preoperative chemoradiation for squamous cell esophageal cancer: a prospective randomized trial. Can J Gastroenterol 12 [Suppl B]: 161
43. Le Prise E, Etienne PL, Meunier B, Maddern G, et al (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73: 1779
44. Leichman L, Silberman H, Leichman CG, Spears CP, et al (1992) Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program. J Clin Oncol 10: 1933
45. Lowy AM, Mansfield PF, Leach SD, Pazdur R, et al (1999) Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 229: 303
46. Macdonald JS, Smalley S, Benedetti J, Estes N, et al (2000) Postoperative combined radiation and chemotherapy improves disease-free survival and overall survival in resected adenocarcinoma of the stomach and GE junction. Proc Am Soc Clin Oncol 19: 1 (A)
47. Metzger R, Leichman CG, Danenberg KD, Danenberg PV, et al (1998) ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol 16: 309
48. Minsky BD (1999) Carcinoma of the esophagus. Part 1: Primary therapy. Oncology (Huntingt) 13: 1225
49. Minsky BD (1999) Carcinoma of the esophagus. Part 2: Adjuvant therapy. Oncology (Huntingt) 13: 1415
50. Monges GM, Seitz JF, Giovannini MF, Gouvernet JM, et al (1996) Prognostic value of p53 protein expression in squamous cell carcinoma of the esophagus. Cancer Detect Prev 20: 63
51. Moore-Joshi M, Danenberg P, Harpole D (2000) Low thymidylate synthase and ERCC1 gene expressions are associated with increased survival after neoadjuvant 5-FU/cisplatin/radiotherapy for esophageal adenocarcinoma. Proc Am Soc Clin Oncol 19: 944 (A)
52. Nekarda H, Gess C, Stark M, Mueller JD, et al (1999) Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma. Br J Cancer 79: 611
53. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, et al (1992) Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16: 1104
54. Plukker JT, Mulder NH, Sleijfer DT, Grond J, Verschueren RC (1991) Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br J Surg 78: 955
55. Rosen HR, Scheithauer W, Jakesz R, Böhmig HJ, et al (1995) Epirubicin, etoposide and cisplatin in the tretment of locally advanced, nonresectable gastric carcinoma - results of a multicentric pilot study. GI Cancer 1: 49
56. Roth JA, Pass HI, Flanagan MM, Graeber GM, et al (1988) Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96: 242
57. Roussel A, Haegele P, Paillot B, Gabin D, et al (1994) Results of the EORTC-GTCCG phase III trial of irradiation vs irradiation and CDDP in inoperable esophageal cancer. Proc Am Soc Clin Oncol 13: 583 (A)
58. Sielezneff I, Thomas P, Giovannini M, Guidicelli R, et al (1993) Esophageal carcinoma with doubtful extirpability. Value of preoperative chemotherapy plus radiotherapy. Eur J Cardiothorac Surg 7: 606
59. Siewert JR, Fink U (1995) Multimodal treatment and prognostic factors in GI cancer - introduction. World J Surg 19: 167
60. Siewert JR, Sendler A, Dittler HJ, Fink U, Höfler H (1995) Staging gastrointestinal cancer as a precondition for multimodal treatment. World J Surg 19: 168
61. Slabber CF, Nel JS, Schoeman L, Burger W, et al (1998) A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol Cancer Clin Trials 21: 462
62. Smith IC, Welch AE, Hutcheon AW, Miller ID, et al (2000) Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol 18: 1676
63. Smith TJ, Ryan LM, Douglass HO, Haller DG, et al (1998) Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42: 269
64. Stahl M (1999) Chemotherapy of esophageal carcinoma. Onkologie 22: 98
65. Theisen J, Fink U, Danenberg K, Ott K, et al (2000) Gene expression as predictor of response in neoadjuvant treated patients with esophageal adenocarcinoma. Proc Am Assoc Cancer Res 41: 4072 (A)
66. Urba S, Orringer M, Turrisi A, Whyte R, et al (1997) A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer: updated analysis. Proc Am Soc Clin Oncol 16: 983 (A)
67. Van Raemdonck D, Van Cutsem E, Menten J, Ectors N, et al (1997) Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration. Eur J Cardiothorac Surg 11: 828
68. Vollmers HP, Timmermann W, Hensel F, Illert B, et al (2000) Adjuvante Immuntherapie beim Magencarcinom durch Antikörper-induzierte Apoptose. Zentralbl Chir 125 [Suppl 1]: 37
69. Walsh TN, McDonell CO, Mulligan ED, Kelly A, et al (2000) Multimodal therapy versus surgery alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. Am J Gastroenterol 118: 1008 (A)
70. Walsh TN, Noonan N, Hollywood D, Kelly A, et al (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335: 462
71. Weber W, Ott K, Fink U, Brücher BL, et al (1999) FDG-PET for monitoring neoadjuvant chemotherapy of adenocarcinomas of the distal esophagus. J Nucl Med 40: 67 (A)
72. Wilke H, Preusser P, Fink U, Gunzer U, et al (1989) Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 7: 1318
73. Yang B, Rice TW, Adelstein DJ, Rybicki LA, Goldblum JR (1999) Overexpression of p53 protein associates decreased response to chemoradiotherapy in patients with esophageal carcinoma. Mod Pathol 12: 251
74. Yano M, Tsujinaka T, Shiozaki H, Inoue M, et al (1999) Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus. J Surg Oncol 70: 25